OptiNose
OptiNose
optinose.com

Locations

Yardley, PA, USA · Oslo, Norway · Oslo, Norway

industry

Biotechnology · DeepTech · Health

Size

51-200 employees

Stage

Other

founded in

2010

OptiNose develops nasal drug delivery technologies and novel combination drug/device therapies. The drug delivery technologies are based upon a unique and patent-protected principal "Bi-Directional Delivery" which allows drugs to be more efficiently delivered to the nasal cavity. By applying its drug delivery technology, most of the dose is deposited beyond the nasal valve in the upper posterior two-thirds of the nasal cavity, unlike traditional devices. The OptiNose delivery devices have high dose reproducibility and avoid drug deposition to the lungs. In summary, technology fulfills the ideal requirements for nasal drug delivery. Clinical trials have shown that devices can provide a faster onset of action, greater effect with a lower dose, and reduced side effects. The company has offices in Norway and the UK.

Something looks off?
Open jobs at OptiNose
Powered by Getro